Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies

IntroductionThis study aimed to determine the characteristics of aphasic mild cognitive impairment (aphasic MCI), which is characterized by a progressive and relatively prominent language impairment compared with other cognitive impairments, in the prodromal phase of dementia with Lewy bodies (DLB)....

Full description

Bibliographic Details
Main Authors: Hiroyuki Watanabe, Sakura Hikida, Manabu Ikeda, Etsuro Mori
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1128566/full
_version_ 1797854159866691584
author Hiroyuki Watanabe
Hiroyuki Watanabe
Hiroyuki Watanabe
Sakura Hikida
Sakura Hikida
Manabu Ikeda
Manabu Ikeda
Etsuro Mori
Etsuro Mori
author_facet Hiroyuki Watanabe
Hiroyuki Watanabe
Hiroyuki Watanabe
Sakura Hikida
Sakura Hikida
Manabu Ikeda
Manabu Ikeda
Etsuro Mori
Etsuro Mori
author_sort Hiroyuki Watanabe
collection DOAJ
description IntroductionThis study aimed to determine the characteristics of aphasic mild cognitive impairment (aphasic MCI), which is characterized by a progressive and relatively prominent language impairment compared with other cognitive impairments, in the prodromal phase of dementia with Lewy bodies (DLB).MethodsOf the 26 consecutive patients with aphasic MCI who had been prospectively recruited at our hospital, 8 patients were diagnosed with prodromal DLB and underwent language, neurological, neuropsychological, and neuroimaging (N-isopropyl-p-[123I] iodoamphetamine single-photon emission computed tomography; IMP-SPECT) testing. Three of these patients also underwent cholinesterase inhibitor therapy with donepezil.ResultsIn our aphasic MCI cohort, the clinical diagnosis of probable prodromal DLB accounted for more than 30% of cases; therefore, the presence of language impairment in prodromal DLB was not very uncommon. Five patients were diagnosed with progressive anomic aphasia and three with logopenic progressive aphasia. Anomic aphasia was characterized by apparent anomia but relatively preserved repetition and comprehension ability and logopenic progressive aphasia by anomia, phonemic paraphasia, and impaired repetition. IMP-SPECT revealed hypoperfusion of the temporal and parietal lobes in the left hemisphere in all but one patient. All patients who underwent cholinesterase inhibitor therapy with donepezil showed improvement in general cognitive function, including language function.DiscussionThe clinical and imaging features of aphasic MCI in prodromal DLB are similar to those observed in Alzheimer's disease. Progressive fluent aphasia, such as progressive anomic aphasia and logopenic progressive aphasia, is one of the clinical presentations in prodromal state of DLB. Our findings provide further insight into the clinical spectrum of prodromal DLB and may contribute to the development of medication for progressive aphasia caused by cholinergic insufficiency.
first_indexed 2024-04-09T20:02:24Z
format Article
id doaj.art-c15337b45c694d8e84d3fc8e3ae5630b
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-09T20:02:24Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-c15337b45c694d8e84d3fc8e3ae5630b2023-04-03T04:22:05ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-04-011410.3389/fneur.2023.11285661128566Aphasic mild cognitive impairment in prodromal dementia with Lewy bodiesHiroyuki Watanabe0Hiroyuki Watanabe1Hiroyuki Watanabe2Sakura Hikida3Sakura Hikida4Manabu Ikeda5Manabu Ikeda6Etsuro Mori7Etsuro Mori8Department of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development, Suita, JapanDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, JapanBrain Function Center, Nippon Life Hospital, Osaka, JapanDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, JapanBrain Function Center, Nippon Life Hospital, Osaka, JapanDepartment of Psychiatry, Osaka University Graduate School of Medicine, Suita, JapanBrain Function Center, Nippon Life Hospital, Osaka, JapanDepartment of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development, Suita, JapanBrain Function Center, Nippon Life Hospital, Osaka, JapanIntroductionThis study aimed to determine the characteristics of aphasic mild cognitive impairment (aphasic MCI), which is characterized by a progressive and relatively prominent language impairment compared with other cognitive impairments, in the prodromal phase of dementia with Lewy bodies (DLB).MethodsOf the 26 consecutive patients with aphasic MCI who had been prospectively recruited at our hospital, 8 patients were diagnosed with prodromal DLB and underwent language, neurological, neuropsychological, and neuroimaging (N-isopropyl-p-[123I] iodoamphetamine single-photon emission computed tomography; IMP-SPECT) testing. Three of these patients also underwent cholinesterase inhibitor therapy with donepezil.ResultsIn our aphasic MCI cohort, the clinical diagnosis of probable prodromal DLB accounted for more than 30% of cases; therefore, the presence of language impairment in prodromal DLB was not very uncommon. Five patients were diagnosed with progressive anomic aphasia and three with logopenic progressive aphasia. Anomic aphasia was characterized by apparent anomia but relatively preserved repetition and comprehension ability and logopenic progressive aphasia by anomia, phonemic paraphasia, and impaired repetition. IMP-SPECT revealed hypoperfusion of the temporal and parietal lobes in the left hemisphere in all but one patient. All patients who underwent cholinesterase inhibitor therapy with donepezil showed improvement in general cognitive function, including language function.DiscussionThe clinical and imaging features of aphasic MCI in prodromal DLB are similar to those observed in Alzheimer's disease. Progressive fluent aphasia, such as progressive anomic aphasia and logopenic progressive aphasia, is one of the clinical presentations in prodromal state of DLB. Our findings provide further insight into the clinical spectrum of prodromal DLB and may contribute to the development of medication for progressive aphasia caused by cholinergic insufficiency.https://www.frontiersin.org/articles/10.3389/fneur.2023.1128566/fullLewy body diseaseAlzheimer's diseasemild cognitive impairmentprimary progressive aphasiacholinesterase inhibitor
spellingShingle Hiroyuki Watanabe
Hiroyuki Watanabe
Hiroyuki Watanabe
Sakura Hikida
Sakura Hikida
Manabu Ikeda
Manabu Ikeda
Etsuro Mori
Etsuro Mori
Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
Frontiers in Neurology
Lewy body disease
Alzheimer's disease
mild cognitive impairment
primary progressive aphasia
cholinesterase inhibitor
title Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
title_full Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
title_fullStr Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
title_full_unstemmed Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
title_short Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
title_sort aphasic mild cognitive impairment in prodromal dementia with lewy bodies
topic Lewy body disease
Alzheimer's disease
mild cognitive impairment
primary progressive aphasia
cholinesterase inhibitor
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1128566/full
work_keys_str_mv AT hiroyukiwatanabe aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT hiroyukiwatanabe aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT hiroyukiwatanabe aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT sakurahikida aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT sakurahikida aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT manabuikeda aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT manabuikeda aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT etsuromori aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies
AT etsuromori aphasicmildcognitiveimpairmentinprodromaldementiawithlewybodies